3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
18
Phase 2
9
Phase 1/2
5
Phase 3
4
Phase 1
4
Phase 4
1
Phase 2/3
1
Status
Completed
9
Recruiting
5
Unknown
2
Terminated
2
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
7
Carcinoma, Hepatocellular
6
Neoplasm Metastasis
5
Leukemia, Myeloid, Acute
5
Colorectal Neoplasms
5
Breast Neoplasms
5
Stomach Neoplasms
4
Rectal Neoplasms
4
Recurrence
3
Ovarian Neoplasms
3
Multiple Myeloma
3
Esophageal Squamous Cell Carcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Hematologic Neoplasms
2
Cholangiocarcinoma
2
Biliary Tract Neoplasms
2
Acute Kidney Injury
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Thymoma
1
Thymic epithelial tumor
1
Squamous NSCLC
1
Squamous Cell Non-small Cell Lung Cancer
1
Small Cell Lung Carcinoma
1
Interventions
toripalimab
1
disitamab vedotin
1
RC48 antibody
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Not yet recruiting
×
Urinary Bladder Neoplasms
×
Clear all
NCT07608224
2026-05-27
HOPE-07-MIBC
West China Hospital
Phase 2/3
Not yet recruiting
240 enrolled